Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Masimo (MASI) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
As of Oct. 10, 2024, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Here's Why You Should Add Masimo Stock to Your Portfolio Now
MASI's R&D activities raise optimism about the stock.
Why Masimo Stock Crushed the Market Today
The medical technology specialist, known for its monitoring devices, named an interim CEO. This followed the resignation of its existing chief.
Masimo's Joe Kiani resigns as CEO after board ouster
Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.
Masimo (MASI) Surges 8.7%: Is This an Indication of Further Gains?
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Masimo CEO Joe Kiani ousted from board after proxy fight; Politan wins two seats
Activist investor Politan won the two board seats it was seeking at Masimo, defeating founder Joe Kiani and another director at the shareholder vote. Politan nominees Darlene Solomon and Bill Jellison will join two others who were added to the board in a prior proxy fight.
Masimo shareholders elect both Politan nominees in bitter boardroom battle
Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles of the year.
MASI Stock Gains as US Court Raises Concern About Politan's Ethics
Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor MASI's founder in the upcoming vote for new board members on Sept.
Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS
MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.
Masimo Stock Likely to Rise With Qualcomm Wear OS Partnership
MASI Collaborates with Qualcomm to develop a reference platform for Wear OS smartwatches, combining biosensing tech and Snapdragon chips to enhance performance and connectivity.
